European Union Drug Approval: Overview of New European Medicines Evaluation Agency and Approval Process
HEHS-96-71
Published: Apr 05, 1996. Publicly Released: Apr 05, 1996.
Skip to Highlights
Highlights
Pursuant to a congressional request, GAO reviewed: (1) the new European Union (EU) procedures for approving new drug applications (NDA); and (2) why the European Medicines Evaluation Agency (EMEA) was established, how it operates, and how it is financed.
Full Report
Office of Public Affairs
Topics
DrugsFood and drug lawForeign governmentsInternational cooperationInternational organizationsProduct evaluationProduct safetySafety regulationDrug approvalsPrescription drugs